» Articles » PMID: 32917952

Central Serous Chorioretinopathy and Heart Rate Variability Analysis with a Smartphone Application

Overview
Journal Sci Rep
Specialty Science
Date 2020 Sep 12
PMID 32917952
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to quantitatively analyze heart rate variability (HRV) in patients with central serous chorioretinopathy (CSC) by using a smartphone-based application (ANBAI: DUMSCO Inc.) for measurement, and to clarify its relationships with CSC. The subjects were 64 CSC patients (mean age 48.7 ± 7.6 years, 57 males and 7 females). After providing consent, the patients downloaded ANBAI apps to their smartphones. HRV was measured by photoelectric volume pulse wave measurement with a smartphone camera each morning for a minimum of 1 week. The primary outcome was to analyze HRV by calculating log LF/HF (Low Frequency/High Frequency components), an index of autonomic tone, which was then compared with a control group of 35,226 individuals from the application. Secondary outcome measures included disease duration, body mass index, exercise habits, smoking history, steroid use, occupation, lifestyle regularity, psychological fatigue, physical fatigue, and average sleep time. The log LF/HF was significantly higher in the patient group than in the control group (P < 0.001). Log LF/HF was significantly lower in patients with exercise habits as a factor contributing to log LF/HF in the patient group (P = 0.019). Analysis of HRV in CSC patients showed an impairment of the autonomic nervous system. Exercise habits may also be associated with CSC.

Citing Articles

The effect of heart rate variability on the choroidal vascularity of the optical coherence tomography and angiography in central serous chorioretinopathy.

Hwang B, Kim J, Park Y Graefes Arch Clin Exp Ophthalmol. 2024; 262(12):3825-3835.

PMID: 39028320 DOI: 10.1007/s00417-024-06575-x.


The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid.

Leclercq B, Weiner A, Zola M, Mejlacowicz D, Lassiaz P, Jonet L Acta Neuropathol. 2023; 146(5):747-766.

PMID: 37682293 PMC: 10564818. DOI: 10.1007/s00401-023-02628-3.


Pupillary Responses Reveal Autonomic Regulation Impairments in Patients With Central Serous Chorioretinopathy.

Zhou X, Fukuyama H, Okita Y, Kanda H, Yamamoto Y, Araki T Invest Ophthalmol Vis Sci. 2022; 63(10):2.

PMID: 36066317 PMC: 9463716. DOI: 10.1167/iovs.63.10.2.


Diagnostic Features and Potential Applications of PPG Signal in Healthcare: A Systematic Review.

Almarshad M, Islam M, Al-Ahmadi S, BaHammam A Healthcare (Basel). 2022; 10(3).

PMID: 35327025 PMC: 8950880. DOI: 10.3390/healthcare10030547.


Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use.

Alsberge J, Lee D, Jumper J Am J Ophthalmol Case Rep. 2022; 26:101482.

PMID: 35308586 PMC: 8924628. DOI: 10.1016/j.ajoc.2022.101482.


References
1.
Kim Y, Woo S, Park K, Chi Y, Han J, Kim K . Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype. Korean J Ophthalmol. 2018; 32(4):281-289. PMC: 6085183. DOI: 10.3341/kjo.2017.0144. View

2.
Lahousen T, Painold A, Luxenberger W, Schienle A, Kapfhammer H, Ille R . Psychological factors associated with acute and chronic central serous chorioretinopathy. Nord J Psychiatry. 2015; 70(1):24-30. DOI: 10.3109/08039488.2015.1041156. View

3.
Yannuzzi L . Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1986; 84:799-845. PMC: 1298752. View

4.
Tsai D, Chen S, Huang C, Chou P, Chung C, Chan W . Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan. Retina. 2014; 34(9):1867-74. DOI: 10.1097/IAE.0000000000000159. View

5.
Nicholson B, Atchison E, Idris A, Bakri S . Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2017; 63(1):1-8. DOI: 10.1016/j.survophthal.2017.06.008. View